Final Results

BLACKROCK GREATER EUROPE INVESTMENT TRUST plc Annual results announcement for the year ended 31 August 2008 KEY POINTS - Revenue return per share of 3.73p (2007: 3.06p), an increase of 21.9%. - Proposed final dividend of 3.00p (2007: 2.40p) per ordinary share, an increase of 25.0%. MANAGEMENT REPORT Chairman's Statement During the year to 31 August 2008, European equities were affected by continued volatility in global financial markets as the true extent of the damage caused by the credit crunch and fears over the state of the global economy began to take effect. Against this difficult background, the Company's net asset value ("NAV") fell by 6.8% during the twelve month period (compared with a fall of 3.4% for the FTSE World Europe ex UK Index) and the share price fell by 11.3% (all percentages calculated in Sterling terms with income reinvested). These falls would have been greater but for the appreciation of the Euro against Sterling over the financial year. Revenue and dividends Revenue per share for the year amounted to 3.73p compared with 3.06p for the corresponding year, a rise of 21.9% reflecting dividend growth from our portfolio companies. The Directors are proposing a final dividend of 3.00p per share, representing an increase of 25.0% on the previous year. The dividend is payable on 3 December 2008 to shareholders on the Company's register on 31 October 2008. Tender offer The Directors exercised their discretion to operate the semi-annual tender offer on 2 June 2008, being the succeeding business day to 31 May, which in common with previous tender offers was for up to a maximum of 20% of the shares in issue at the prevailing NAV less 2%. Valid tenders for 2,728,833 shares were received at a price of 179.68p per share, representing 2.37% of the shares in issue at the time. All shares tendered on this occasion have been placed in treasury and the 4,726,178 shares previously held in treasury were cancelled in line with the Directors' policy. It was announced on 8 September 2008 that the next semi-annual tender offer would take place on 1 December 2008, being the succeeding business day to 30 November, for up to 20% of shares in issue at the prevailing NAV per share subject to a discount of 2%. Portfolio manager change The Board is pleased to report the appointment of Vincent Devlin as co-portfolio manager of the Company with effect from 31 July 2008. Mr Devlin succeeds James Macmillan, who together with Sam Vecht managed the Company's portfolio since its launch in September 2004. Mr Macmillan has stepped down to focus on his European Value and International Value funds and we wish to thank him for his contribution. Mr Vecht will continue to manage the emerging Europe part of the Company's portfolio. Mr Devlin has fourteen years' experience in fund management and more than ten years' managing European equities. He joined BlackRock in January 2008. New Articles of Association At the forthcoming Annual General Meeting, the Directors will be proposing that the Company should adopt New Articles of Association in substitution for the existing Articles of Association in order to reflect the changes in UK company law which have been brought into force by the Companies Act 2006 (the "2006 Act".) The 2006 Act is being introduced in stages and is expected to be fully in force by 1 October 2009. Outlook Following the recent turmoil in financial markets and the substantial declines in equity markets, it now appears that, as a result of the determination of governments to underpin the banking sector there is hope that the markets worst fears may be avoided. Nevertheless, many countries, including the major European countries, are now facing the prospect of a possibly protracted recession. European equity market values will recover when there is some certainty and confidence in economic recovery and corporate earnings, and the picture will become clearer in the coming year. In the meantime, your Company will continue to seek to invest in those European companies which it considers to be excellent long term investments. Key risks The key risks faced by the Company are set out below. The Board regularly reviews and agrees policies for managing each risk, as summarised below. - Performance risk - The Board is responsible for deciding the investment strategy to fulfil the Company's objective and monitoring the performance of the Investment Manager. An inappropriate strategy may lead to underperformance against the reference index and the Company's peer group. To manage this risk the Investment Manager provides an explanation of significant stock selection decisions and the rationale for the composition of the investment portfolio. The Board monitors and mandates an adequate spread of investments, in order to minimise the risks associated with particular countries or factors specific to particular sectors, based on the diversification requirements inherent in the Company's investment policy. The Board also receives and reviews regular reports showing an analysis of the Company's performance against the FTSE World Europe ex UK Index and other similar indices. - Income/dividend risk - The amount of dividends and future dividend growth will depend on the Company's underlying portfolio. Any change in the tax treatment of the dividends or interest received by the Company (including as a result of withholding taxes or exchange controls imposed by jurisdictions in which the Company invests) may reduce the level of dividends received by shareholders. The Board monitors this risk through the receipt of detailed income forecasts and considers the level of income at each meeting. - Regulatory risk - The Company operates as an investment trust in accordance with section 842 of ICTA 1988. As such the Company is exempt from capital gains tax on the sale of its investments. The Investment Manager monitors investment movements, the level and type of forecast income and expenditure and the amount of proposed dividends to ensure that the provisions of section 842 are not breached and the results are reported to the Board. - Operational risk - Like most other investment trust companies, the Company has no employees. The Company therefore relies upon the services provided by third parties and is dependent on the control systems of the Investment Manager and the Company's service providers. The security, for example, of the Company's assets, dealing procedures, accounting records and maintenance of regulatory and legal requirements, depend on the effective operation of these systems. These are regularly tested and monitored and an internal control report, which includes an assessment of risks together with procedures to mitigate such risks, is prepared by the Investment Manager and reviewed by the Audit and Management Engagement Committee twice a year. The custodian and the Investment Manager also produce annual AAF 01/06 and SAS 70 reports which are reviewed by their respective auditors and give assurance regarding the effective operation of controls. - Financial risks - The Company's investment activities expose it to a variety of financial risks that include market price risk, foreign currency risk, interest rate risk, liquidity risk and credit risk. In addition, it should be noted that emerging markets tend to be more volatile than more established stock markets and therefore present a greater degree of risk. Related party transactions The Investment Manager is regarded as a related party and details of the investment management fees payable are set out in note 4. Statement of Directors' Responsibilities In accordance with Disclosure and Transparency Rule 4.1.12, the Directors confirm to the best of their knowledge that: - the financial statements, prepared in accordance with applicable accounting standards, give a true and fair view of the assets, liabilities, financial position and profit or loss of the Company; and - the annual report includes a fair view of the development and performance of the business and the position of the Company, together with a description of the principal risks and uncertainties that the Company faces. For and on behalf of the Board of Directors John Walker-Haworth Chairman 17 October 2008 INVESTMENT MANAGER'S REPORT The main features of European financial markets in the twelve month period to 31 August 2008 were the number of ripple effects that resulted from the global credit crisis. These included a rapid slowdown in the European economy as low business and consumer confidence coincided with rising raw material prices, significantly lower property prices mirroring trends seen in the US and the UK, and a reduction of debt levels by banks and other lending institutions looking to repair their balance sheets in response to tightening credit availability. Against this backdrop, the Company saw a decline of 11.3% in the share price with the underlying NAV falling by 6.8% in the twelve month period ended 31 August 2008, both with income reinvested. By comparison, the FTSE World Europe ex UK Index declined by 3.4% (with income reinvested). The appreciation of crude oil and other resources which began in 1998 but reached its peak in the summer of 2008, gave rise to some awkward consequences for policy makers, companies and consumers alike. For policy makers there was growing concern over the tendency for inflation to rise and this prevented the European Central Bank ("ECB") from adopting a more accommodating stance in response to the economic weakness that emerged in the second quarter of the financial year. For directors of companies, their biggest concern was the rise in the input costs of their businesses and, in an environment of softening demand, the ability to pass these increases on to their customers depended on the level of industry concentration and hence pricing power in their industry. The rise in oil, metals and electricity prices during the period under review was also accompanied by a substantial increase in food prices, resulting in an overall decrease in consumer spending power. However, this was partly mitigated by the strength of the Euro, which appreciated by 16.3% against Sterling, as well as reaching record levels against other currencies. Corporate earnings in 2008 remained robust outside of the financial sector which had borne the brunt of the write-downs and many companies, especially export led sectors, continued to benefit from the favourable trends in global industrial production, particularly in the developing countries where GDP growth remained at a premium to the developed world. The sectors that thrived in the stock market have generally been closely tied to the underlying fundamentals of their industries, so shares in financials generally suffered material declines; other poor performing areas included the consumer sectors, especially automobiles and media as well as selected industrials, while energy and resources shares performed positively. These trends peaked in mid summer and we witnessed a period of reversal, prompted by the rapid decline in the oil price from its peak at close to US$150 a barrel. Over the period under review, the Company's performance was hampered by its investments in the stock markets of emerging Europe despite the MSCI Emerging Europe Index returning 1.6%. An average of 12.6% of the Company's net assets were invested in emerging Europe and contributions from Poland, Russia, Turkey and the BlackRock Eurasian Frontiers Hedge Fund were negative. The Company's performance also suffered due to modest gearing in a declining market. During the twelve month period to 31 August 2008, stock selection made an overall negative impact on performance. This was mostly due to exposure within the financial sector including the holdings in Fortis, Société Générale and Dom Maklerski IDM which were affected by continued turmoil in global credit markets. In addition, selected holdings in the energy sector performed poorly in response to the falling oil price and a re-pricing of risk in the wake of political uncertainty in Russia. These included the holdings in StatoilHydro and Total, as well as Russian based companies Integra, Transneft and Surgutneftegaz. Elsewhere, the Company's holdings in Telecom Italia and Praktiker also produced negative returns. Stocks which contributed positively to performance were mainly found in the health care sector, one of the best performing sectors over the year, benefiting from strong revenue growth and lack of correlation to the economic cycle. A good example is clinical research provider ICON which grew revenues in excess of 30% and was a beneficiary of outsourcing trends from large pharmaceutical companies. Elsewhere in the sector, holdings in Fresenius, Novartis and Bayer were also advantageous. In addition, other solid stocks included selected holdings in the technology sector which included Ness Technologies and Cap Gemini. The Company significantly reduced its weighting in the financial sector during the period under review; this was achieved mainly by cutting exposure to banks on concerns that the ongoing credit crisis would continue to impact negatively on the sector. The Company also reduced exposure to the automobile sector due to a clear emergence of slowing in the European consumer sector as well as rising input costs. Proceeds were partially reinvested into defensive areas of the market such as consumer staples and health care, as well as capital goods and utilities. The emerging market exposure declined during the year under review to close at 10.3%, with the largest exposures being Russia and the BlackRock Eurasian Frontiers Hedge Fund which provided diversified exposure to the region. In addition, the Company also reduced its net market exposure from 109% to 99%. At the end of the review period the Company had a bias towards financials, but still retained an underweight position relative to the reference benchmark, especially in banks and diversified financials, with a small overweight position in insurance. Other key sector positions included health care and industrials. The Company had limited exposure to consumer sectors, especially consumer staples, although we had been gradually building positions in selected names. We continue to favour companies with a combination of robust balance sheets, comprising low gearing, cash generating business models and an ability to pass on price increases or cut costs through self help measures or restructuring. We place emphasis on good earnings visibility and earnings growth as we believe these companies should be resilient in a downturn. The Company maintains a bias toward large capitalisation stocks. Outlook The worldwide economic slowdown that emerged back in 2007 still clearly presents a challenge for global equity markets. The US market has already coped with a material slowdown and has experienced significant reductions in interest rates. However, continental Europe has lagged and it is only in recent months that there has been a meaningful deterioration in business and consumer confidence, as well as economic growth. In addition, with inflation measures now peaking and continued downward revisions to growth, investors are anticipating further policy easing in 2009. This could act as a catalyst for the market and would be a further stimulus for a weaker Euro which would boost European competitiveness and profitability especially in export led sectors. In the current climate it is difficult to have certainty on the direction of European corporate earnings and it is probable that market estimates for the current year may be too high and could be revised down. However, we believe that this has been reflected in equity market valuations where significant earnings risk has already been priced in and where we have seen the market de-rate to multi year lows. In the coming months we anticipate consolidation driven by companies with strong balance sheets. In emerging Europe we expect the economic slowdown to feed through to the region, hence absolute growth rates are likely to be subdued. In Russia, the investor focus on politics, rather than fundamentals, points to ongoing volatility in the short term. However, for the investor with a longer term view, this environment offers some extraordinary value. We expect to see inflationary pressures ease across the region, as the combined effects of falling fuel and food prices are factored in. This should be particularly beneficial for Turkey, where consumer confidence is increasing and the AK Party can concentrate on its reform programme. While there may be more volatility in equity markets over the coming months, we believe that over the longer term greater Europe offers many attractive investment opportunities and that the recent sell-off provides a good opportunity to purchase holdings in leading European companies at historically low valuations. Vincent Devlin & Sam Vecht BlackRock Investment Management (UK) Limited 17 October 2008 Key Holdings 31 August 2008 Seven Largest European Holdings Novartis - 4.9% (2007: 3.3%) is a Swiss based pharmaceutical company engaged in the development and manufacture of pharmaceuticals and nutritional products. Growth prospects are superior to the industry and pipeline risk is relatively less than other major peers. Valuation is attractive relative to the growth prospects. Roche - 4.2% (2007: 2.7%) is a Swiss based pharmaceuticals and diagnostics company. Roche has the most defensive product portfolio, with a pipeline that continues to deliver and with limited exposure to drug expiries and generics risk. Roche is strong in specialty pharmaceuticals with lower risk of pricing pressure and limited patent risk. Valuation remains attractive given earnings growth prospects. Allianz - 4.0% (2007: 2.6%) is a leading German based insurance group with significant operations throughout Europe. Its core activities include traditional life, health and property & casualty insurance with a skew towards non life. We prefer non life insurers to life insurers due to the higher cash flow generation and more resilient earnings power and we continue to prefer insurers to banks due to their relatively strong capital positions and low exposures to toxic assets. Allianz management has now also dealt with Dresdner, the most problematic part of the company, by selling the investment bank to Commerzbank above book value. Allianz will retain a stake in the combined entity and should therefore benefit from the large cost synergy potential. Nestlé - 3.8% (2007: nil) is a Swiss based food producer focusing on milk, chocolate, confectionary and coffee products. It has a broad geographic reach and a diversified stream of income. The company offers defensive characteristics which we find attractive in the current market environment and valuation is undemanding. E.On - 3.4% (2007: 2.6%) is a German based utility engaged in power and gas generation. The company has an attractive generation mix with 50% in low carbon emission and is therefore well positioned to continue to benefit from the rising power and electricity prices. With additional optionality in Russia, combined with good earnings visibility and an attractive valuation, we believe this is one of the more favourable names in the sector. StatoilHydro - 3.4% (2007: 2.1%) is one of Europe's leading integrated oil and gas companies and the largest operator on the Norwegian continental shelf. We believe it stands out among its European peer group due to sector leading production growth, its high quality Exploration & Production (E&P) portfolio and its superior leverage to raising oil and gas prices. With over 90% of group earnings derived from the E&P division, the Norwegian government has a mandate to increase its stake which is supportive for this share price. Bayer - 3.3% (2007: 4.3%) is a German Pharmaceutical and Chemicals company with strong market positions and a promising product pipeline. Following the successful takeover bid for Schering, the company has benefited from a re-rating of the business towards higher multiples on the back of cost savings from the integration of Schering and new drug launches. In the medium term, significant changes in the current Group structure could also be value accretive as the company increasingly focuses on its pharmaceutical business. Management has a strong reputation and we see significant absolute upside from the current share price. Three Largest Emerging European Holdings BlackRock Eurasian Frontiers Hedge Fund - 4.3% (2007: 3.1%) is a hedge fund generating its returns from Eastern European, Middle Eastern and "frontier" markets through a variety of strategies. The fund has returned -7.7% during the year under review. Polski Koncern Naftowy Orlen - 1.1% (2007: nil) is a Polish oil refiner with a diverse product mix, including petrol, diesel, heating oil and aviation fuel. The company trades on an attractive multiple and is a beneficiary of the easing price of crude oil. Ness Technologies - 1.0% (2007: nil) is an Israeli IT outsourcing company focused on software development, system integration and consulting. We took a position as the stock had began to look oversold. Investors became concerned about the company's exposure to any slowdown in the US economy; however the business has proved to be robust and we see continued upside from the current share price. Investments 31 August 2008 Book Market Country of cost value % of operation £'000 £'000 investments Financials Allianz Germany 7,668 7,492 4.0 Zurich Financial Services Switzerland 6,346 5,962 3.1 BNP Paribas France 5,014 5,168 2.7 Credit Suisse Switzerland 5,633 4,919 2.6 Intesa Sanpaolo Italy 5,830 4,547 2.4 Société Générale France 3,858 4,336 2.3 Bank of Cyprus Cyprus 4,220 3,957 2.1 AFI Development Russia 1,862 1,188 0.6 Dom Maklerski Poland 3,036 992 0.5 ------ ------ ---- 43,467 38,561 20.3 ------ ------ ---- Health Care Novartis Switzerland 8,675 9,272 4.9 Roche Switzerland 8,113 7,936 4.2 Fresenius Germany 2,247 4,664 2.4 Icon Ireland 3,065 3,612 1.9 ------ ------ ---- 22,100 25,484 13.4 ------ ------ ---- Industrials GEA Germany 6,162 5,474 2.9 Siemens Germany 4,878 5,204 2.7 Alstom France 4,942 4,653 2.5 Bouygues France 3,920 3,962 2.1 Deutsche Post Germany 3,186 2,881 1.5 Koza Daetiyeleri Turkey 1,864 1,040 0.5 ------ ------ ---- 24,952 23,214 12.2 ------ ------ ---- Utilities E.On Germany 5,322 6,580 3.4 GDF Suez France 5,690 5,271 2.8 Fortum Finland 4,202 4,132 2.2 Électricité de France France 2,246 3,690 1.9 Red Eléctrica Spain 1,912 2,041 1.1 Suez France 588 687 0.4 ------ ------ ---- 19,960 22,401 11.8 ------ ------ ---- Basic Materials Bayer Germany 3,875 6,300 3.3 ArcelorMittal Steel Netherlands 3,114 5,240 2.8 Akzo Nobel Netherlands 3,927 3,417 1.8 Norsk Hydro Norway 3,373 2,829 1.5 ------ ------ --- 14,289 17,786 9.4 ------ ------ --- Oil & Gas StatoilHydro Norway 7,688 6,396 3.4 Saipem Italy 2,979 2,738 1.4 Vestas Wind Systems Denmark 1,729 2,035 1.1 Polski Koncern Naftowy Orlen Poland 2,212 2,002 1.1 Surgutneftegaz Russia 2,165 1,586 0.8 Transneft Russia 1,812 1,198 0.6 Integra Russia 2,531 1,088 0.6 ------ ------ --- 21,116 17,043 9.0 ------ ------ --- Telecommunications Telefonica Spain 5,114 4,707 2.5 KPN Netherlands 4,125 4,206 2.2 Telecom Italia Italy 4,327 2,505 1.3 ------ ------ --- 13,566 11,418 6.0 ------ ------ --- Consumer Goods Nestlé Switzerland 7,300 7,076 3.8 Compagnie Financiere Richemont Switzerland 3,636 3,771 2.0 Africa-Israel Israel 1,068 422 0.2 ------ ------ --- 12,004 11,269 6.0 ------ ------ --- Consumer Services Opap Greece 5,434 5,368 2.8 Vivendi France 4,695 5,315 2.8 ------ ------ --- 10,129 10,683 5.6 ------ ------ --- Technology Cap Gemini France 1,779 1,991 1.0 Ness Technologies Israel 1,176 1,749 1.0 ----- ----- --- 2,955 3,740 2.0 ----- ----- --- Other BlackRock Eurasian Frontiers Hedge Emerging Fund Europe 6,026 8,085 4.3 ----- ----- --- 6,026 8,085 4.3 ------- ------- ----- Total investments 190,564 189,684 100.0 ------- ------- ----- All investments are in ordinary shares unless otherwise stated. The total number of investments held at 31 August 2008 was 47 (31 August 2007: 58). Investment Exposure Investment Size as at 31 August 2008 Number of % of Investments Portfolio <£1m 3 1.1 £1m to £2m 7 5.1 £2m to £3m 7 9.0 £3m to £4m 6 11.8 >£4m 24 73.0 -- ----- 47 100.0 -- ----- Market Capitalisation as at 31 August 2008 % of % of Portfolio Reference Index <€5bn 20.5 8.8 €5bn to €10bn 8.0 11.7 €10bn to €20bn 10.3 17.7 €20bn to €50bn 25.4 31.0 >€50bn 35.8 30.8 ----- ----- 100.0 100.0 ----- ----- Distribution of Investments as at 31 August 2008 Portfolio Financials 20.3 Health Care 13.4 Industrials 12.2 Utilities 11.8 Basic Materials 9.4 Oil & Gas 9.0 Telecommunications 6.0 Consumer Goods 6.0 Consumer Services 5.6 Technology 2.0 Other 4.3 ----- 100.0 ----- Source: BlackRock INCOME STATEMENT for the year ended 31 August 2008 Revenue Revenue Capital Capital Total Total 2008 2007 2008 2007 2008 2007 Notes £'000 £'000 £'000 £'000 £'000 £'000 (Losses)/ gains on investments held at fair value through profit or loss - - (16,847) 34,318 (16,847) 34,318 Income from investments held at fair value through profit or loss 3 6,998 6,642 - - 6,998 6,642 Other income 3 26 7 - - 26 7 Investment management and performance fees 4 (202) (252) (754) (1,472) (956) (1,724) Operating expenses 5 (667) (775) - - (667) (775) ----- ----- ------- ------ ------- ------ Net return/ (loss) before finance costs and taxation 6,155 5,622 (17,601) 32,846 (11,446) 38,468 Finance costs (101) (212) (402) (850) (503) (1,062) ----- ----- ------- ------ ------- ------ Return/(loss) on ordinary activities before taxation 6,054 5,410 (18,003) 31,996 (11,949) 37,406 Taxation on ordinary activities (1,746) (1,587) 153 310 (1,593) (1,277) ------ ------ ------- ------ ------- ------ Return/(loss) on ordinary activities after taxation 4,308 3,823 (17,850) 32,306 (13,542) 36,129 ----- ----- ------- ------ ------- ------ Return/(loss) per ordinary share - basic and diluted 7 3.73p 3.06p (15.44p) 25.87p (11.71p) 28.93p ===== ===== ======= ====== ======= ====== The total column of this statement represents the Income Statement of the Company. The supplementary revenue and capital columns are both prepared under guidance published by the Association of Investment Companies. The Company had no recognised gains or losses other than those disclosed in the Income Statement and the Reconciliation of Movements in Shareholders' Funds. All items in the above statement derive from continuing operations. No operations were acquired or discontinued during the year. RECONCILIATION OF MOVEMENTS IN SHAREHOLDERS' FUNDS Share Share Capital capital premium redemption Special Capital Revenue £'000 account reserve reserve reserve reserve Total £'000 £'000 £'000 £'000 £'000 £'000 For the year ended 31 August 2008 At 31 August 2007 125 151 39 103,213 112,554 5,249 221,331 (Loss)/return for the year - - - - (17,850) 4,308 (13,542) Shares purchased (10) - 10 (13,705) - - (13,705) Share purchase costs - - - (168) - - (168) Dividend paid* - - - - - (2,876) (2,876) --- --- --- ------ ------ ----- ------- At 31 August 2008 115 151 49 89,340 94,704 6,681 191,040 === === === ====== ====== ===== ======= For the year ended 31 August 2007 At 31 August 2006 134 151 30 121,679 80,248 4,031 206,273 Return for the year - - - - 32,306 3,823 36,129 Shares purchased (9) - 9 (18,187) - - (18,187) Share purchase costs - - - (279) - - (279) Dividend paid** - - - - - (2,605) (2,605) --- --- --- ------- ------- ----- ------- At 31 August 2007 125 151 39 103,213 112,554 5,249 221,331 === === === ======= ======= ===== ======= * Final dividend paid in respect of the year ended 31 August 2007 of 2.40p per share declared on 16 October 2007 and paid on 6 December 2007. ** Final dividend paid in respect of the period ended 31 August 2006 of 2.00p per share declared on 16 October 2006 and paid on 30 November 2006. BALANCE SHEET as at 31 August 2008 2008 2007 Notes £'000 £'000 Fixed assets Investments held at fair value through profit or loss 189,684 237,326 Current assets Debtors 1,059 7,121 Cash 1,735 49 ------- ------- 2,794 7,170 ------- ------- Creditors - amounts falling due within one year Bank overdrafts - (19,783) Other creditors (843) (2,954) ------- ------- (843) (22,737) ------- ------- Net current assets/(liabilities) 1,951 (15,567) ------- ------- Total assets less current liabilities 191,635 221,759 Provision for liabilities and charges (595) (428) ------- ------- Net assets 191,040 221,331 ======= ======= Capital and reserves Share capital 8 115 125 Share premium account 151 151 Capital redemption reserve 49 39 Special reserve 89,340 103,213 Capital reserve 94,704 112,554 Revenue reserve 6,681 5,249 ------- ------- Total equity shareholders' funds 191,040 221,331 ======= ======= Net asset value per ordinary share 7 169.98p 184.68p ======= ======= CASH FLOW STATEMENT for the year ended 31 August 2008 2008 2007 Note £'000 £'000 Net cash inflow from operating activities 5(b) 3,736 3,354 Servicing of finance (503) (1,086) Taxation paid (305) (455) Capital expenditure and financial investment Purchase of investments (200,542) (230,290) Proceeds from sale of investments 236,004 237,238 Realised (losses)/gains on foreign currency transactions (158) 138 ------- ------- Net cash inflow from capital expenditure and financial investment 35,304 7,086 ------- ------- Equity dividends paid (2,876) (2,605) ------- ------- Net cash inflow before financing 35,356 6,294 ------- ------- Financing Purchase of ordinary shares (13,705) (18,187) Share purchase costs (182) (176) ------- ------- Net cash outflow from financing (13,887) (18,363) ------- ------- Increase/(decrease) in cash in the year 21,469 (12,069) ======= ======= Notes to the ANNUAL RESULTS ANNOUNCEMENT 1. Principal activity The principal activity of the Company is that of an investment trust company within the meaning of section 842 of the Income and Corporation Taxes Act 1988. 2. Accounting policies a) Basis of preparation The Company's financial statements have been prepared in accordance with UK Generally Accepted Accounting Practice ("UK GAAP") and with the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies' ("SORP") revised in December 2005. The principal accounting policies adopted by the Company are set out below. All of the Company's operations are of a continuing nature. The Company's financial statements are presented in Sterling, which is the currency of the primary economic environment in which the Company operates. All values are rounded to the nearest thousand pounds (£'000) except where otherwise indicated. b) Presentation of Income Statement In order to reflect better the activities of an investment trust company and in accordance with guidance issued by the Association of Investment Companies ("AIC"), supplementary information which analyses the Income Statement between items of a revenue and capital nature has been presented alongside the Income Statement. In accordance with the Company's status as a UK investment company under section 833 of the Companies Act 2006, net capital returns may not be distributed by way of dividend. c) Segmental reporting The Directors are of the opinion that the Company is engaged in a single segment of business being investment business. d) Income Dividends receivable on equity shares are treated as revenue for the year on an ex-dividend basis. Where no ex-dividend date is available, dividends receivable on or before the year end are treated as revenue for the year. Provisions are made for dividends not expected to be received. Fixed returns on debt securities are recognised on a time apportionment basis. Interest income and expenses are accounted for on an accruals basis. e) Expenses All expenses are accounted for on an accruals basis. Expenses have been treated as revenue except as follows: - expenses which are incidental to the acquisition or disposal of an investment are included with the cost of the investment; - the investment management fee has been allocated 80% to capital reserve and 20% to the revenue account in line with the Board's expected long term split of returns, in the form of capital gains and income respectively, from the investment portfolio; - to the extent that any performance fees arise, they are allocated between revenue and capital reserves in line with the respective contribution to performance of revenue and capital returns. f) Finance costs Finance costs are accounted for on an accruals basis. Finance costs are allocated, insofar as they relate to the financing of the Company's investments, 80% to capital reserves and 20% to the revenue account, in line with the Board's expected long term split of returns, in the form of capital gains and income respectively, from the investment portfolio. g) Taxation Deferred taxation is recognised in respect of all temporary timing differences at the balance sheet date, where transactions or events that result in an obligation to pay more tax in the future or right to pay less tax in the future have occurred at the balance sheet date. This is subject to deferred taxation assets only being recognised if it is considered more likely than not that there will be suitable profits from which the future reversal of the temporary differences can be deducted. h) Investments held at fair value through profit or loss The Company's investments are classified as held at fair value through profit or loss in accordance with FRS 26 - Financial Instruments: Recognition and Measurement and are managed and evaluated on a fair value basis in accordance with its investment strategy. All investments are designated upon initial recognition as held at fair value through profit or loss. Sales of assets are recognised at the trade date of the disposal. Proceeds will be measured at fair value which will be regarded as the proceeds of sale less any transaction costs. The fair value of the financial instruments is based on their quoted bid price at the balance sheet date, without deduction for the estimated future selling costs. Unquoted investments are valued by the Directors at fair value using International Private Equity and Venture Capital Association Guidelines. This policy applies to all current and non current asset investments of the Company. Changes in the value of investments held at fair value through profit or loss and gains and losses on disposal are recognised in the Income Statement as "Gains or losses on investments held at fair value through profit or loss". Also included within this heading are transaction costs in relation to the purchase or sale of investments. i) Dividends payable Under FRS 21 final dividends should not be accrued in the financial statements unless they have been approved by shareholders before the balance sheet date. Dividends payable to equity shareholders are recognised in the Reconciliation of Movement in Shareholders' Funds when they have been approved by the shareholders and become a liability of the Company. j) Foreign currency translation All transactions in foreign currencies are translated into Sterling at the rates of exchange ruling on the dates of such transactions. Foreign currency assets and liabilities at the balance sheet date are translated into Sterling at the exchange rates ruling at that date. Exchange differences arising on the revaluation of investments held as fixed assets are included in capital reserve. Exchange differences arising on the translation of foreign currency assets and liabilities are taken to capital reserve. 3. Income 2008 2007 £'000 £'000 Investment income: UK dividends 57 33 Overseas dividends 6,941 6,609 ----- ----- 6,998 6,642 Other income: Deposit interest 26 7 ----- ----- Total 7,024 6,649 ===== ===== 4. Investment management and performance fees 2008 2007 Revenue Capital Total Revenue Capital Total £'000 £'000 £'000 £'000 £'000 £'000 Investment management fees 202 807 1,009 223 891 1,114 Performance fees - - - - 409 409 VAT (written back)/ charged - (53) (53) 29 172 201 --- --- --- --- ----- ----- Total 202 754 956 252 1,472 1,724 === === === === ===== ===== The investment management fee is levied quarterly, based on the value of the market capitalisation on the last day of each month. Investment management fees for the year amounted to £1,009,000 (2007: £1,114,000). The performance fee accrued at 31 August 2007 was based on the outperformance of the Company's share price relative to the FTSE World Europe ex UK Index over a three year rolling period. No performance fee was accrued for the year ended 31 August 2008 (2007: £409,000). The credit of £53,000 relates to VAT arising on the performance fee accrued at 31 August 2007. Following the outcome of the JPMorgan Claverhouse case, management fees are now exempt from VAT and VAT on the performance fee has been written back accordingly, as this amount had not been invoiced at the date HMRC ceded the case. 5. Operating activities 2008 2007 £'000 £'000 (a) Operating activities Custody fee 79 89 Auditors' remuneration: - audit services 23 22 - non audit services* 5 4 Directors' emoluments 74 67 Registrar's fees and other operating expenses 486 593 ---- ---- 667 775 ==== ==== The Company's total expense ratio ("TER"), calculated as a percentage of average net assets and using expenses, excluding performance fees and interest costs, after relief for taxation was: 0.6% 0.7% * Non audit services relate to the review of the half yearly financial statements. 2008 2007 £'000 £'000 (b) Reconciliation of net (loss)/return before finance costs and taxation to net cash flow from operating activities Net (loss)/return before finance costs and taxation (11,446) 38,468 Losses/(gains) on investments held at fair value through profit or loss 16,847 (34,318) Decrease in accrued income 87 104 Decrease in other debtors 31 10 (Decrease)/increase in creditors (607) 81 Tax on investment income included within gross income (1,176) (991) ------ ----- Net cash inflow from operating activities 3,736 3,354 ====== ===== 6. Dividends The Directors have proposed a final dividend of 3.00p per share in respect of the year ended 31 August 2008. The dividend will be paid on 3 December 2008 subject to shareholders' approval on 25 November 2008 to shareholders on the Company's register on 31 October 2008. The proposed final dividend has not been included as a liability in these financial statements as final dividends are only recognised in the financial statements when they have been approved by shareholders. The dividends disclosed in the note below have been considered in view of the requirements of section 842 of the Income and Corporation Taxes Act 1988 and section 833 of the Companies Act 2006, and the amounts proposed meet the relevant requirements as set out in this legislation. 2008 2007 £'000 £'000 Dividend payable on equity shares: Final proposed of 3.00p* (2007: 2.40p) 3,372 2,876 ----- ----- 3,372 2,876 ===== ===== *Based on 112,388,958 ordinary shares in issue on 16 October 2008. 7. Return and net asset value per ordinary share Revenue and capital returns per share are shown below and have been calculated using the following: 2008 2007 Net revenue return attributable to ordinary shareholders (£'000) 4,308 3,823 Net capital (loss)/return attributable to ordinary shareholders (£'000) (17,850) 32,306 ------- ------- Net total (loss)/return (£'000) (13,542) 36,129 ======= ======= Equity shareholders' funds (£'000) 191,040 221,331 The weighted average number of ordinary shares in issue during the year, on which the return per ordinary share was calculated, was: 115,644,222 124,871,436 The actual number of ordinary shares in issue at the year end, on which the net asset value was calculated, was: 112,388,958 119,843,969 The number of ordinary shares in issue including treasury shares at the year end, was: 115,117,791 124,729,045 2008 2007 Revenue Capital Total Revenue Capital Total Return per share Calculated on weighted average number of shares 3.73p (15.44p) (11.71p) 3.06p 25.87p 28.93p Calculated on actual number of shares 3.83p (15.88p) (12.05p) 3.19p 26.96p 30.15p Net asset value per share 169.98p 184.68p 8. Share capital Ordinary Treasury shares shares number number Total (nominal) (nominal) shares £ Authorised share capital comprised: Ordinary shares of 0.1p each 900,000,000 - 900,000,000 900,000 ----------- ---------- ----------- ------- Allotted, issued and fully paid: Shares in issue at 31 August 2007 119,843,969 4,885,076 124,729,045 124,729 Shares transferred into treasury pursuant to tender offer on 30 November 2007 (4,726,178) 4,726,178 - - Shares cancelled from treasury on 3 December 2007 - (4,885,076) (4,885,076) (4,885) Shares transferred into treasury pursuant to tender offer on 2 June 2008 (2,728,833) 2,728,833 - - Shares cancelled from treasury on 3 June 2008 - (4,726,178) (4,726,178) (4,726) ----------- --------- ----------- ------- At 31 August 2008 112,388,958 2,728,833 115,117,791 115,118 =========== ========= =========== ======= During the year, 7,455,011 ordinary shares were purchased (2007: 10,394,963) for a total consideration including expenses of £13,873,000 (2007: £18,466,000) and a total of 9,611,254 (2007: 8,976,051) shares were subsequently cancelled. The number of ordinary shares in issue at the year end was 115,117,791 of which 2,728,833 were held in treasury (2007: 4,885,076). There were no sales of shares out of treasury during the year (2007: nil). 9. Publication of non-statutory accounts The financial information contained in this announcement does not constitute statutory accounts as defined in section 435 of the Companies Act 2006. The 2008 annual report and financial statements will be filed with the Registrar of Companies after the Annual General Meeting. The report of the auditor for the year ended 31 August 2008 contains no qualification or statement under section 498(2) or (3) of the Companies Act 2006. 10. Copies of the annual report will be sent to members shortly and will be available from the registered office, c/o The Company Secretary, BlackRock Greater Europe Investment Trust plc, 33 King William Street, London EC4R 9AS. This report will also be available on the BlackRock Investment Management website at www.blackrock.co.uk/. 11. The Annual General Meeting of the Company will be held at the offices of BlackRock Investment Management (UK) Limited, 33 King William Street, London EC4R 9AS on Tuesday, 25 November 2008 at 2.30 p.m. For further information please contact: Jonathan Ruck Keene, Managing Director, Investment Company Division - 020 7743 2178 Vincent Devlin, Fund Manager - 0131 472 7376 Emma Phillips, Media & Communications - 020 7743 2922 BlackRock Investment Management (UK) Ltd Or William Clutterbuck - 020 7379 5151 The Maitland Consultancy 33 King William Street London EC4R 9AS 17 October 2008
UK 100

Latest directors dealings